A quote from
November 15, 2007
APH: TSX-V
LETTER TO THE SHAREHOLDERS OF ALDA PHARMACEUTICALS CORP.
"Europe – The Company is in the process of filing additional information with the European Patent Office. Once this is completed early in the new year, it is anticipated that the European patent will be issued since patents have been allowed in the US, China and Australia with no modifications required to the claims."